3
ICAP

january, 2018

CoVPN 3502 The HEROIC StudyDistricts (or national):Harlem

Project Details

Closed to enrollment and study follow-up Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2 More information: https://clinicaltrials.gov/ct2/show/NCT04452318 https://clinicalresearch.itmat.upenn.edu/clinicaltrial/6567/covid-covid19-healthy-volunteers-covpn-3502-regeneron/